Abstract
Malignant mesothelioma is a rare and aggressive neoplasm with a median survival of less than 12 months and a 5-year survival rate of less than 5%. Malignant pleural mesothelioma is usually a diffuse disease with male predominance and occurs in the 6th to the 7th decade of life. Sixty-nine to 90% of the cases have environmental or occupational exposure to asbestos. Localized malignant mesotheliomas are very rare with only a few published case reports. We report a case of a 37-year-old woman, a homemaker, with localized malignant mesothelioma which presented as a chest wall tumor and was managed by a multidisciplinary team approach. The patient is currently 24 months post-op and is doing well with no recurrence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
We have the patient data available.
References
Rossi G, Davoli F, Poletti V, Cavazza A, Lococo F (2021) When the diagnosis of mesothelioma challenges textbooks and guidelines. J Clin Med 10(11):2434
Okike N, Bernatz PE, Woolner LB (1978) Localized mesothelioma of the pleura: benign and malignant variants. J Thorac Cardiovasc Surg 75(3):363–372
Kim KC, Vo HP (2016) Localized malignant pleural sarcomatoid mesothelioma misdiagnosed as benign localized fibrous tumor. J Thorac Dis 8(6):E379
Yao W, Yang H, Huang G, Yan Y, Wang H, Sun D (2015) Massive localized malignant pleural mesothelioma (LMPM): manifestations on computed tomography in 6 cases. Int J Clin Exp Med 8(10):18367
Hino T, Kamitani T, Sagiyama K, Yamasaki Y, Okamoto I, Tagawa T, Ijichi K, Yamamoto H, Yabuuchi H, Honda H (2019) Localized malignant pleural mesothelioma mimicking an anterior mediastinal tumor. Eur J Radiol Open 1(6):72–77
Sauter JL, Dacic S, Galateau-Salle F, Attanoos RL, Butnor KJ, Churg A, Husain AN, Kadota K, Khoor A, Nicholson AG, Roggli V (2022) The 2021 WHO classification of tumors of the pleura: advances since the 2015 classification. J Thorac Oncol 17(5):608–622
Cramer G, Simone CB, Busch TM, Cengel KA (2018) Adjuvant, neoadjuvant, and definitive radiation therapy for malignant pleural mesothelioma. J Thorac Dis 10(Suppl 21):S2565
Acknowledgements
The authors would like to thank Dr. Sindhu and Dr. Ashok, Department of Pathology, Sagar Hospital, Jayanagar for their help in the description of histopathology features and Dr. H. K. Ramakrishna for his valuable suggestions on proof reading of the manuscript.
Author information
Authors and Affiliations
Contributions
Both authors have contributed equally.
Corresponding author
Ethics declarations
Ethical Approval
A copy of ethics committee certificate is attached for review.
Compliance with Ethical Standards
We have informed and written consent to report this case.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Reddy, C.M., Reddy, H.V.R. Malignant Sarcomatoid Pleural Mesothelioma Presenting as a Chest Wall Tumor. Indian J Surg 85 (Suppl 2), 548–551 (2023). https://doi.org/10.1007/s12262-022-03555-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-022-03555-5